{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:30:23Z","timestamp":1760985023833,"version":"build-2065373602"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Department of Pharmaceutical Sciences, South Dakota State University"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.ejmech.2014.03.040","type":"journal-article","created":{"date-parts":[[2014,3,20]],"date-time":"2014-03-20T01:01:08Z","timestamp":1395277268000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Synthesis of substituted pyrimidines as corticotropin releasing factor (CRF) receptor ligands"],"prefix":"10.1016","volume":"78","author":[{"given":"Bhimanna","family":"Kuppast","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katerina","family":"Spyridaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Liapakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hesham","family":"Fahmy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2014.03.040_bib1","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.6267699","article-title":"Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin","volume":"213","author":"Vale","year":"1981","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2014.03.040_bib2","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJM199505183322008","article-title":"The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation","volume":"332","author":"Chrousos","year":"1995","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.ejmech.2014.03.040_bib3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0031-6997(25)06673-6","article-title":"Physiology and pharmacology of corticotropin-releasing factor","volume":"43","author":"Owens","year":"1991","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.ejmech.2014.03.040_bib4","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/sj.mp.4001032","article-title":"Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH\/NE states","volume":"7","author":"Gold","year":"2002","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.ejmech.2014.03.040_bib5","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0196-9781(01)00398-9","article-title":"Hyperactivity of CRH neuronal circuits as a target for therapeutic interventions in affective disorders","volume":"22","author":"Keck","year":"2001","journal-title":"Peptides"},{"key":"10.1016\/j.ejmech.2014.03.040_bib6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1471-4892(01)00117-5","article-title":"Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression","volume":"2","author":"Reul","year":"2002","journal-title":"Current Opinion in Pharmacology"},{"key":"10.1016\/j.ejmech.2014.03.040_bib7","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0196-9781(01)00388-6","article-title":"Molecular biology of the CRH receptors\u2013 in the mood","volume":"22","author":"Dautzenberg","year":"2001","journal-title":"Peptides"},{"key":"10.1016\/j.ejmech.2014.03.040_bib8","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/378284a0","article-title":"Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease","volume":"378","author":"Behan","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2014.03.040_bib9","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/319593a0","article-title":"Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease","volume":"319","author":"De Souza","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2014.03.040_bib10","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/ni719","article-title":"Corticotropin-releasing hormone promotes blastocyst implantation and early maternal tolerance","volume":"2","author":"Makrigiannakis","year":"2001","journal-title":"Nature Immunology"},{"key":"10.1016\/j.ejmech.2014.03.040_bib11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.7326\/0003-4819-129-3-199808010-00012","article-title":"Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: clinical implications","volume":"129","author":"Chrousos","year":"1998","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.ejmech.2014.03.040_bib12","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0022-3565(24)36470-5","article-title":"Central injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks CRF- and stress-related alterations of gastric and colonic motor function","volume":"280","author":"Martinez","year":"1997","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.ejmech.2014.03.040_bib13","first-page":"164","article-title":"Corticotropin-releasing hormone in humans","volume":"13","author":"Orth","year":"1992","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.ejmech.2014.03.040_bib14","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0196-9781(01)00396-5","article-title":"Cardiovascular actions of CRH and urocortin: an update","volume":"22","author":"Parkes","year":"2001","journal-title":"Peptides"},{"key":"10.1016\/j.ejmech.2014.03.040_bib15","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1172\/JCI12869","article-title":"Corticotropin-releasing hormone regulates IL-6 expression during inflammation","volume":"108","author":"Venihaki","year":"2001","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.ejmech.2014.03.040_bib16","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1006\/frne.1999.0179","article-title":"Animal models of CRH deficiency","volume":"20","author":"Venihaki","year":"1999","journal-title":"Frontiers in Neuroendocrinology"},{"key":"10.1016\/j.ejmech.2014.03.040_bib17","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/BF03346896","article-title":"Human endometrium as a neuroendocrine tissue: expression, regulation and biological roles of endometrial corticotropin-releasing hormone (CRH) and opioid peptides","volume":"20","author":"Zoumakis","year":"1997","journal-title":"Journal of Endocrinological Investigation"},{"key":"10.1016\/j.ejmech.2014.03.040_bib18","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1073\/pnas.80.15.4851","article-title":"Characterization of rat hypothalamic corticotropin-releasing factor","volume":"80","author":"Rivier","year":"1983","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.ejmech.2014.03.040_bib19","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/j.1460-2075.1983.tb01499.x","article-title":"Isolation and sequence analysis of the human corticotropin-releasing factor precursor gene","volume":"2","author":"Shibahara","year":"1983","journal-title":"The EMBO Journal"},{"key":"10.1016\/j.ejmech.2014.03.040_bib20","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/0006-291X(84)91222-1","article-title":"Isolation and characterization of caprine corticotropin-releasing factor","volume":"122","author":"Ling","year":"1984","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.ejmech.2014.03.040_bib21","doi-asserted-by":"crossref","first-page":"8762","DOI":"10.1073\/pnas.82.24.8762","article-title":"Isolation and amino acid sequence of corticotropin-releasing factor from pig hypothalami","volume":"82","author":"Patthy","year":"1985","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.ejmech.2014.03.040_bib22","first-page":"1716","article-title":"Characterization of the genomic corticotropin-releasing factor (CRF) gene from Xenopus laevis: two members of the CRF family exist in amphibians","volume":"6","author":"Stenzel-Poore","year":"1992","journal-title":"Molecular Endocrinology"},{"key":"10.1016\/j.ejmech.2014.03.040_bib23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1399-3011.1981.tb02047.x","article-title":"Amino acid composition and sequence analysis of sauvagine, a new active peptide from the skin of Phyllomedusa sauvagei","volume":"18","author":"Montecucchi","year":"1981","journal-title":"International Journal of Peptide and Protein Research"},{"key":"10.1016\/j.ejmech.2014.03.040_bib24","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1126\/science.6981844","article-title":"Complete amino acid sequence of urotensin I, a hypotensive and corticotropin-releasing neuropeptide from Catostomus","volume":"218","author":"Lederis","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2014.03.040_bib25","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1073\/pnas.051626398","article-title":"Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors","volume":"98","author":"Reyes","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.ejmech.2014.03.040_bib26","doi-asserted-by":"crossref","first-page":"7570","DOI":"10.1073\/pnas.121165198","article-title":"Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor","volume":"98","author":"Lewis","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.ejmech.2014.03.040_bib27","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.1073\/pnas.80.22.6770","article-title":"Structural homology of corticotropin-releasing factor, sauvagine, and urotensin I: circular dichroism and prediction studies","volume":"80","author":"Pallai","year":"1983","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.ejmech.2014.03.040_bib28","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1146\/annurev.pharmtox.44.101802.121410","article-title":"CRF and CRF receptors: role in stress responsivity and other behaviors","volume":"44","author":"Bale","year":"2004","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/j.ejmech.2014.03.040_bib29","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/0306-4530(95)00011-9","article-title":"Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders","volume":"20","author":"De Souza","year":"1995","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ejmech.2014.03.040_bib30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0165-6147(02)01946-6","article-title":"The CRF peptide family and their receptors: yet more partners discovered","volume":"23","author":"Dautzenberg","year":"2002","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.ejmech.2014.03.040_bib31","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0079-6468(02)41006-5","article-title":"Antagonists of the corticotropin releasing factor receptor","volume":"41","author":"Saunders","year":"2003","journal-title":"Progress in Medicinal Chemistry"},{"key":"10.1016\/j.ejmech.2014.03.040_bib32","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1517\/14728222.9.4.651","article-title":"The corticotropin-releasing factor receptor: a novel target for the treatment of depression and anxiety-related disorders","volume":"9","author":"Grigoriadis","year":"2005","journal-title":"Expert Opinion on Therapeutic Targets"},{"key":"10.1016\/j.ejmech.2014.03.040_bib33","doi-asserted-by":"crossref","first-page":"12004","DOI":"10.1073\/pnas.0803216105","article-title":"Central amygdala glucocorticoid receptor action promotes fear-associated CRH activation and conditioning","volume":"105","author":"Kolber","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.ejmech.2014.03.040_bib34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.brainres.2009.10.059","article-title":"Angiotensin II and CRF receptors in the central nucleus of the amygdala mediate hemodynamic response variability to cocaine in conscious rats","volume":"1309","author":"Watanabe","year":"2010","journal-title":"Brain Research"},{"key":"10.1016\/j.ejmech.2014.03.040_bib35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0006-8993(95)00043-P","article-title":"Brain corticotropin-releasing factor mediates \u2018anxiety-like\u2019 behavior induced by cocaine withdrawal in rats","volume":"675","author":"Sarnyai","year":"1995","journal-title":"Brain Research"},{"key":"10.1016\/j.ejmech.2014.03.040_bib36","doi-asserted-by":"crossref","first-page":"17198","DOI":"10.1073\/pnas.0707585104","article-title":"CRF-CRF1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats","volume":"104","author":"George","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.ejmech.2014.03.040_bib37","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1021\/jm990590f","article-title":"Corticotropin releasing factor (CRF) receptor modulators: progress and opportunities for new therapeutic agents","volume":"43","author":"Gilligan","year":"2000","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.ejmech.2014.03.040_bib38","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.drudis.2010.02.011","article-title":"Progress in corticotropin-releasing factor-1 antagonist development","volume":"15","author":"Zorrilla","year":"2010","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.ejmech.2014.03.040_bib39","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0006-8993(02)03189-X","article-title":"Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat","volume":"952","author":"Zorrilla","year":"2002","journal-title":"Brain Research"},{"key":"10.1016\/j.ejmech.2014.03.040_bib40","doi-asserted-by":"crossref","first-page":"5747","DOI":"10.1210\/endo.137.12.8940412","article-title":"In\u00a0vivo and in\u00a0vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation","volume":"137","author":"Webster","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejmech.2014.03.040_bib41","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1210\/endo.140.1.6415","article-title":"The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress","volume":"140","author":"Deak","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejmech.2014.03.040_bib42","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0006-8993(00)02742-6","article-title":"Antalarmin blockade of corticotropin releasing hormone-induced hypertension in rats","volume":"881","author":"Briscoe","year":"2000","journal-title":"Brain Research"},{"key":"10.1016\/j.ejmech.2014.03.040_bib43","first-page":"1252","article-title":"Corticotropin releasing hormone (CRH) antagonist attenuates adjuvant induced arthritis: role of CRH in peripheral inflammation","volume":"29","author":"Webster","year":"2002","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.ejmech.2014.03.040_bib44","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2982.2005.00648.x","article-title":"Corticotropin-releasing factor 1 receptor-mediated mechanisms inhibit colonic hypersensitivity in rats","volume":"17","author":"Greenwood-Van Meerveld","year":"2005","journal-title":"Neurogastroenterology and Motility: The Official Journal of the European Gastrointestinal Motility Society"},{"key":"10.1016\/j.ejmech.2014.03.040_bib45","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.2174\/138161206778743637","article-title":"CRF1 receptors as a therapeutic target for irritable bowel syndrome","volume":"12","author":"Martinez","year":"2006","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.ejmech.2014.03.040_bib46","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/sj.mp.4001031","article-title":"Marked suppression of gastric ulcerogenesis and intestinal responses to stress by a novel class of drugs","volume":"7","author":"Gabry","year":"2002","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.ejmech.2014.03.040_bib47","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/BF00900005","article-title":"Zur Chemie der 4-aminothiazolin-2-thione","volume":"112","author":"Gewald","year":"1981","journal-title":"Monatshefte fur Chemie"},{"key":"10.1016\/j.ejmech.2014.03.040_bib48","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0223-5234(93)90002-V","article-title":"Potential anti-microbials. II. Synthesis and in\u00a0vitro anti-microbial evaluation of some thiazolo[4,5-d]pyrimidines","volume":"28","author":"Badawey","year":"1993","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/j.ejmech.2014.03.040_bib49","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/S0960-894X(99)00159-6","article-title":"Thiazolo[4,5-d]pyrimidine thiones and -ones as corticotropin-releasing hormone (CRH-R1) receptor antagonists","volume":"9","author":"Beck","year":"1999","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"10.1016\/j.ejmech.2014.03.040_bib50","unstructured":"J. Beck. Thiazolo[4, 5-d] pyrimidines and pyridines as corticotropin releasing factor (CRF) antagonists, in, WO Patent 1,999,051,608, 1999."},{"key":"10.1016\/j.ejmech.2014.03.040_bib51","first-page":"28","article-title":"synthesis of some new thiazolo[4,5-d]pyrimidine derivatives and evaluation of their antifungal, antiviral and cytotoxic activities","volume":"6","author":"El Sherbeny","year":"1996","journal-title":"Medicinal Chemistry Research"},{"key":"10.1016\/j.ejmech.2014.03.040_bib52","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/BF00811521","article-title":"Zur Chemie der 4-Amino-thiazolin-2-thione, 2. Mitt","volume":"125","author":"Gewald","year":"1994","journal-title":"Monatshefte fur Chemie Chemical Monthly"},{"key":"10.1016\/j.ejmech.2014.03.040_bib53","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1070\/MC2003v013n04ABEH001753","article-title":"Solvent-free Pd-catalysed N-arylation of amines, amides and diaza-18-crown-6","author":"Artamkina","year":"2003","journal-title":"Mendeleev Communications"},{"key":"10.1016\/j.ejmech.2014.03.040_bib54","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1124\/mol.108.052423","article-title":"Alanine scanning mutagenesis of the second extracellular loop of type 1 corticotropin-releasing factor receptor revealed residues\u00a0critical for peptide binding","volume":"75","author":"Gkountelias","year":"2009","journal-title":"Molecular Pharmacology"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523414002530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523414002530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:41:29Z","timestamp":1759326089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523414002530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":54,"alternative-id":["S0223523414002530"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2014.03.040","relation":{},"ISSN":["0223-5234"],"issn-type":[{"type":"print","value":"0223-5234"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis of substituted pyrimidines as corticotropin releasing factor (CRF) receptor ligands","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2014.03.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}